Jan Nilsson, CEO
Jan Nilsson was appointed CEO of CombiGene in October 2016. Jan has a vast experience both from large pharmaceutical companies and from biotech companies. Jan has been involved in many areas in the pharmaceutical industry spanning from early drug development to sales and marketing of established international brands. Jan has extensive leadership experience and has served as CEO both in public and in private companies.
Karin Agerman, Chief Research and Development Officer
Karin Agerman has more than fifteen years of experience from the international pharmaceutical industry and from the start-up arena in Sweden. She has worked at AstraZeneca, Merck and Uppsala BIO in several senior positions. The work has included preclinical drug discovery, marketing and sales. Her network is extensive in both industry and academia as well as in the political arena.